Market Research Logo

Elixir Medical Corporation - Product Pipeline Analysis, 2016 Update

Summary

Elixir Medical Corporation (Elixir Medical) is a medical device company that manufactures and distributes drug eluting stent systems for the healthcare sector. The company’s products include next-generation drug-eluting stent systems, bioresorbable scaffolds, cardiology devices, eluting coronary stent systems, eluting bioresorbable coronary scaffold systems, and coronary stent systems. Its other products comprise pipeline products, small vessel stent systems, fully absorbable drug eluting scaffold stent systems, advanced pharmaceutical products, and others. Elixir Medical offers services such as research and development, polymer coating technology services, bioabsorbal material solutions, innovating vascular restoration, clinical trials, clinical studies, drug delivery services, and others. The company operates in the US and Ireland. Elixir Medical is headquartered in Sunnyvale, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Elixir Medical Corporation
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Table of Contents
List of Tables
List of Figures
Elixir Medical Corporation Company Snapshot
Elixir Medical Corporation Company Overview
Key Information
Elixir Medical Corporation Pipeline Products and Clinical Trials Overview
Elixir Medical Corporation - Major Products and Services
Elixir Medical Corporation Pipeline Products by Development Stage
Elixir Medical Corporation Pipeline Products Overview
DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System
DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System Product Overview
DESyne Nx Novolimus Eluting Coronary Stent System
DESyne Nx Novolimus Eluting Coronary Stent System Product Overview
Myolimus Eluting Coronary Stent - Durable Polymer
Myolimus Eluting Coronary Stent - Durable Polymer Product Overview
Peripheral Vascular Resorbable Scaffold
Peripheral Vascular Resorbable Scaffold Product Overview
Elixir Medical Corporation - Key Competitors
Elixir Medical Corporation - Key Employees
Elixir Medical Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Elixir Medical Corporation, Recent Developments
Oct 15, 2015: Elixir Medical Announces Excellent, 3-year Clinical and Imaging Results for the CE-Marked Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System
Oct 13, 2015: Elixir Medical Announces Successful Live Case Transmission of DESolve Cx at TCT 2015
Aug 18, 2015: Elixir Medical Receives 2015 Innovator of the Year Award from EK-UNICO
May 20, 2015: Elixir Medical Announces Excellent, 3-year Imaging Results for the CE-Marked Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System
May 13, 2015: Elixir Medical to Showcase Results for the Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold Systems at EuroPCR 2015
Sep 08, 2014: Elixir Medical Announces Schedule of Programs for TCT 2014
May 23, 2014: Elixir Medical Announces Outstanding Long-Term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-Approved Novolimus Eluting Coronary Intervention Systems
May 23, 2014: Elixir Medical Announces Results for CE mark-approved DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System at EuroPCR
May 23, 2014: Elixir Medical Announces Clinical Trial Results of DESyne BD Novolimus Eluting Coronary Stent System at EuroPCR
May 23, 2014: Elixir Medical Announces Outstanding Long-term Clinical Results of DESyne Novolimus Eluting Coronary Stent System at EuroPCR
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Elixir Medical Corporation, Key Facts
Elixir Medical Corporation Pipeline Products and Clinical Trials Overview
Elixir Medical Corporation Pipeline Products by Equipment Type
Elixir Medical Corporation Pipeline Products by Indication
Elixir Medical Corporation, Major Products and Services
Elixir Medical Corporation Number of Pipeline Products by Development Stage
Elixir Medical Corporation Pipeline Products Summary by Development Stage
DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System - Product Status
DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System - Product Description
DESyne Nx Novolimus Eluting Coronary Stent System - Product Status
DESyne Nx Novolimus Eluting Coronary Stent System - Product Description
Myolimus Eluting Coronary Stent - Durable Polymer - Product Status
Myolimus Eluting Coronary Stent - Durable Polymer - Product Description
Peripheral Vascular Resorbable Scaffold - Product Status
Peripheral Vascular Resorbable Scaffold - Product Description
Elixir Medical Corporation, Key Employees
Elixir Medical Corporation, Other Locations
List of Figures
Elixir Medical Corporation Pipeline Products by Equipment Type
Elixir Medical Corporation Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report